This study evaluates the antimicrobial susceptibility and composition of
subgingival biofilms in generalized aggressive periodontitis (GAP) patients
treated using mechanical/antimicrobial therapies, including chlorhexidine (CHX),
amoxicillin (AMX) and metronidazole (MET). GAP patients allocated to the placebo
(C, n = 15) or test group (T, n = 16) received full-mouth disinfection with CHX,
scaling and root planning, and systemic AMX (500 mg)/MET (250 mg) or placebos.
Subgingival plaque samples were obtained at baseline, 3, 6, 9 and 12 months
post-therapy from 3–4 periodontal pockets, and the samples were pooled and
cultivated under anaerobic conditions. The minimum inhibitory concentrations
(MICs) of AMX, MET and CHX were assessed using the microdilution method.
Bacterial species present in the cultivated biofilm were identified by
checkerboard DNA-DNA hybridization. At baseline, no differences in the MICs
between groups were observed for the 3 antimicrobials. In the T group,
significant increases in the MICs of CHX (p < 0.05) and AMX (p < 0.01)
were detected during the first 3 months; however, the MIC of MET decreased at 12
months (p < 0.05). For several species, the MICs significantly changed over
time in both groups, i.e., Streptococci MICs
tended to increase, while for several periodontal pathogens, the MICs
diminished. A transitory increase in the MIC of the subgingival biofilm to AMX
and CHX was observed in GAP patients treated using enhanced mechanical therapy
with topical CHX and systemic AMX/MET. Both protocols presented limited effects
on the cultivable subgingival microbiota.